{"name":"Sintetica SA","slug":"sintetica-sa","ticker":"","exchange":"","domain":"sintetica.com","description":"","hq":"Mendrisio","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Chloroprocaine HCl 2%","genericName":"Chloroprocaine HCl 2%","slug":"chloroprocaine-hcl-2","indication":"Local anesthesia for infiltration, nerve block, and epidural anesthesia","status":"phase_3"},{"name":"Chloroprocaine 1% Injectable Solution","genericName":"Chloroprocaine 1% Injectable Solution","slug":"chloroprocaine-1-injectable-solution","indication":"Local infiltration anesthesia for minor surgical procedures","status":"marketed"},{"name":"Chloroprocaine 2% Injectable Solution","genericName":"Chloroprocaine 2% Injectable Solution","slug":"chloroprocaine-2-injectable-solution","indication":"Spinal anesthesia","status":"phase_2"},{"name":"Chloroprocaine 3%","genericName":"Chloroprocaine 3%","slug":"chloroprocaine-3","indication":"Local anesthesia for infiltration, nerve block, and epidural anesthesia","status":"phase_3"},{"name":"Chloroprocaine HCl 1%","genericName":"Chloroprocaine HCl 1%","slug":"chloroprocaine-hcl-1","indication":"Regional anesthesia for surgical procedures","status":"phase_2"},{"name":"Hyperbaric Bupivacaine HCl 0.5%","genericName":"Hyperbaric Bupivacaine HCl 0.5%","slug":"hyperbaric-bupivacaine-hcl-0-5","indication":"Other","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Chloroprocaine 3% eye gel","genericName":"Chloroprocaine 3% eye gel","slug":"chloroprocaine-3-eye-gel","indication":"Topical anesthesia of the eye for diagnostic procedures and minor ocular surgery","status":"phase_3"}]}],"pipeline":[{"name":"Chloroprocaine HCl 2%","genericName":"Chloroprocaine HCl 2%","slug":"chloroprocaine-hcl-2","phase":"phase_3","mechanism":"Chloroprocaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.","indications":["Local anesthesia for infiltration, nerve block, and epidural anesthesia"],"catalyst":""},{"name":"Chloroprocaine 1% Injectable Solution","genericName":"Chloroprocaine 1% Injectable Solution","slug":"chloroprocaine-1-injectable-solution","phase":"marketed","mechanism":"Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.","indications":["Local infiltration anesthesia for minor surgical procedures","Nerve blocks and regional anesthesia"],"catalyst":""},{"name":"Chloroprocaine 2% Injectable Solution","genericName":"Chloroprocaine 2% Injectable Solution","slug":"chloroprocaine-2-injectable-solution","phase":"phase_2","mechanism":"Local anesthetic by blocking sodium channels","indications":["Spinal anesthesia"],"catalyst":""},{"name":"Chloroprocaine 3%","genericName":"Chloroprocaine 3%","slug":"chloroprocaine-3","phase":"phase_3","mechanism":"Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.","indications":["Local anesthesia for infiltration, nerve block, and epidural anesthesia"],"catalyst":""},{"name":"Chloroprocaine 3% eye gel","genericName":"Chloroprocaine 3% eye gel","slug":"chloroprocaine-3-eye-gel","phase":"phase_3","mechanism":"Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses in the eye.","indications":["Topical anesthesia of the eye for diagnostic procedures and minor ocular surgery"],"catalyst":""},{"name":"Chloroprocaine HCl 1%","genericName":"Chloroprocaine HCl 1%","slug":"chloroprocaine-hcl-1","phase":"phase_2","mechanism":"Chloroprocaine HCl 1% is a local anesthetic that works by blocking nerve impulses in the body.","indications":["Regional anesthesia for surgical procedures"],"catalyst":""},{"name":"Hyperbaric Bupivacaine HCl 0.5%","genericName":"Hyperbaric Bupivacaine HCl 0.5%","slug":"hyperbaric-bupivacaine-hcl-0-5","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQLV9OUC1JbnRLRzNoXzRpSEFVdnJkMW9DREZaY0IyS0ctOTk2UGQ4eURIUXlYQ2gzbWZWWXhXVHYxZEJtWlU5T3BwMmRhRk54LU1NNnY3SmxmX1E2emoyWHlWbGNJTWdtcTFaSlk2NGg4X29MeGpud1pxTjZFRHdKb2xvdy1Kd1pVTHY0MjRwa19pa2NhNjFPbk1NMTlMVVFhTzJTMklvRFdCWlNDZklIdGw0VjV5Zw?oc=5","date":"2025-09-10","type":"regulatory","source":"Ticino Welcome","summary":"Farma Industria Ticino confirms its team: Waldo Mossi remains Vice President - Ticino Welcome","headline":"Farma Industria Ticino confirms its team: Waldo Mossi remains Vice President","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQVJOcXgxbnlBa0xkZS1kYnFZRlV1cTlEcEppa0JhLVRzQnlhUU5zRlRlckFQeVNDc1BfUmZNYlF1UlliMFZFZlZmZ19hMVpkeFpsUnJlUS1QQ2hSQVlpbFhUMG5BYTJQWnBWdHJ5QlhvbjZMd1EyN3RHT01RbVY4ZmRPR2dGUmFWWUJUS1dIMjZOQWNHRWV0Zm9XSW9UUXV1c29uZ2F3c042aWdYR00tcnpfTTgzam9kNll0a1RYQy1mT2s?oc=5","date":"2025-04-14","type":"pipeline","source":"Ticino Welcome","summary":"Luca Bolzani: “More research, to the advantage of companies” - Ticino Welcome","headline":"Luca Bolzani: “More research, to the advantage of companies”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOX1Bpa3FpSllFRlRHVXR1eURaam1KZjQ1YnUxbnhjaEpfejUwdnhmUDY0bGtPWTEtY2ZfbFR5a3FIMFZPc1FXNjZtd25zR0NXeXd3RTQ1QmZtSHZnRHhTS3ZOSWU4eC0tZlhfWWdzMGJickx0eUZPSUk3RGRaZkJjUkxzTXVEMkJQTUNqV3VkZXktdjkwNDlvMHdNV2VhaTRhQkJXOXVSZVVGTmdWenl4VmNoc0RQZ2Zld0V6Vks1NDk3ZFE?oc=5","date":"2023-03-27","type":"pipeline","source":"prnewswire.com","summary":"Sintetica US launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4% - prnewswire.com","headline":"Sintetica US launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxOUWppa1JUMl8wb0ZDRXYwNDk0T3had25XOGVVMEM5UXlKMVFGby1ZNF93NkNaRjRna19nOGNiNHdjbEY0WGwzQjViSTA0WkJDU2NNVm9VTEhic3U4c0NkdWp3ckNEQ0Z5RzdmVVdMaDExZ1lJLWdVUUFnYnZPRlRRZWIyRndNRGFRdHIwVGxuMXhRdWxKbzBOeURIQk9rU0taUlBpQXRLamZKNDRyWWlFWmk5OHVsVW9MQWVmbXJwOG9Od3ppNTNmbTNBLUxPZzRqVnNZM0VMSVJELUJGY1FnUnZuQkx3bldKLXVvV2VqNXVrcWRqZkMxLWJ1dWVjWjhyX0pwcXpvdmNrQTFoX1pibEYwQ1dtWXc4OWsyczkzb3dkZmJW?oc=5","date":"2022-09-27","type":"pipeline","source":"The Chronicle-Journal","summary":"User - The Chronicle-Journal","headline":"User - The Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQaEltbENqdnY5TnZFNEZkdVBKVzMxMHRuOTlDZ3ZPaEp3LTRPZTRBbUFybzlqdmdtV3RjdTZBVnJMY0NkVlptNGxLMHZkSHF6eUZFVXQ4X0RwdnJUeEJqQnI0U1NZYThiZThsbXBERWJrYWtsbnFscTQ5bzFRcWhvRzI0aFltbTItVFFXVmtxQXhkWmxzX3BabWdUaTRXNEFlVEo0a2h1dS1SdmJoUVg4WkNDLUJiaGR0eFRiSGpqc3NUZUpXSnkwZVJQNGtLLTFYUG5Haw?oc=5","date":"2021-07-27","type":"deal","source":"businesswire.com","summary":"Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica - businesswire.com","headline":"Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9CNU1RT1N0T0NFWENYLXNPbE9QZ1UtRGpYVlo0bU95bVVfSzNfUVQzZ1hBelZMY09abmRFaEs3OE5qVXVzaVJkbXpubGlCZ0xTUVpjcXpvdU0xcmlHOUUycnd1WEV0TXF4aG83WFdqVk8zaWVMb1lKSEtn?oc=5","date":"2019-09-23","type":"pipeline","source":"pf-media.co.uk","summary":"Darren Fergus talks why trust matters - pf-media.co.uk","headline":"Darren Fergus talks why trust matters - pf","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":3,"marketed":2,"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}